Higher fasting fibroblast growth factor 21 was associated with a greater decline in postprandial blood pressure.

[1]  R. DeFronzo,et al.  FGF21 Contributes to Metabolic Improvements Elicited by Exenatide and Pioglitazone in Patients with Type 2 Diabetes. , 2022, American journal of physiology. Endocrinology and metabolism.

[2]  C. Kendall,et al.  Systematic review and meta-analysis examining the relationship between postprandial hypotension, cardiovascular events, and all-cause mortality , 2022, The American journal of clinical nutrition.

[3]  M. Horowitz,et al.  Effects of age on blood pressure and heart rate responses to whey protein in younger and older men , 2021, Journal of the American Geriatrics Society.

[4]  S. Oparil,et al.  The Story of the Silent Killer , 2020, Current Hypertension Reports.

[5]  A. Nakashima,et al.  Pre-impaired fasting glucose state is a risk factor for endothelial dysfunction: Flow-mediated Dilation Japan (FMD-J) study , 2020, BMJ open diabetes research & care.

[6]  K. Izawa,et al.  Postprandial Blood Pressure Decrease in Patients with Type 2 Diabetes and Mild or Severe Cardiac Autonomic Dysfunction , 2019, International journal of environmental research and public health.

[7]  K. Tsintzas,et al.  FGF21 Is an Insulin-Dependent Postprandial Hormone in Adult Humans , 2017, The Journal of clinical endocrinology and metabolism.

[8]  K. Lam,et al.  Fibroblast Growth Factor 21 Mimetics for Treating Atherosclerosis , 2017, Endocrinology and metabolism.

[9]  Yun Zhao,et al.  Postprandial changes in glucose oxidation and insulin sensitivity in metabolic syndrome: Influence of fibroblast growth factor 21 and vitamin D status. , 2017, Nutrition.

[10]  C. Bondor,et al.  The metabolic hormone FGF21 is associated with endothelial dysfunction in hemodialysis patients , 2017, International Urology and Nephrology.

[11]  M. Soares,et al.  Prevailing vitamin D status influences mitochondrial and glycolytic bioenergetics in peripheral blood mononuclear cells obtained from adults , 2016, Redox biology.

[12]  W. Shou,et al.  FGF21 ameliorates the neurocontrol of blood pressure in the high fructose-drinking rats , 2016, Scientific Reports.

[13]  S. Chanprasertyothin,et al.  Serum fibroblast growth factor 21 in overweight and obese Thai children and adolescents: its relation to glucose metabolism and its change after glucose loading , 2015, Clinical endocrinology.

[14]  J. Son,et al.  Effects of the amount of rice in meals on postprandial blood pressure in older people with postprandial hypotension: a within-subjects design. , 2015, Journal of clinical nursing.

[15]  H. Fu,et al.  The effects of LY2405319, an FGF21 analog, in obese human subjects with type 2 diabetes. , 2013, Cell metabolism.

[16]  L. Ferrucci,et al.  Elevated serum fibroblast growth factor 21 is associated with hypertension in community-dwelling adults , 2013, Journal of Human Hypertension.

[17]  Chaoming Wu,et al.  Dynamic change of serum FGF21 levels in response to glucose challenge in human. , 2012, The Journal of clinical endocrinology and metabolism.

[18]  Y. Bao,et al.  Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans. , 2011, Clinical chemistry.

[19]  M. Martínez-Chantar,et al.  Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease. , 2010, Gastroenterology.

[20]  M. Soares,et al.  Postprandial hypotension in older Australians: Relationship to glycaemia and habitual food intake , 2007 .

[21]  W. Pan,et al.  The fasting polypeptide FGF21 can enter brain from blood , 2007, Peptides.

[22]  R. O’Brien,et al.  A Caution Regarding Rules of Thumb for Variance Inflation Factors , 2007 .

[23]  J. Shaw,et al.  Metabolic syndrome—a new world‐wide definition. A Consensus Statement from the International Diabetes Federation , 2006, Diabetic medicine : a journal of the British Diabetic Association.

[24]  D. Bloomfield,et al.  Upright Posture and Postprandial Hypotension in Elderly Persons , 2000, Annals of Internal Medicine.

[25]  T. Ogihara,et al.  Mechanisms mediating postprandial blood pressure reduction in young and elderly subjects. , 1996, American journal of hypertension.

[26]  L. Lipsitz,et al.  Postprandial Hypotension: Epidemiology, Pathophysiology, and Clinical Management , 1995, Annals of Internal Medicine.

[27]  N. Christensen,et al.  Central hemodynamic changes after ingestion of a meal in patients with coronary artery disease. , 1989, Archives of internal medicine.

[28]  D. B. Zilversmit.  Atherogenesis: a postprandial phenomenon. , 1979, Circulation.